Humacyte Inc (HUMAW NASDAQ) stock market data APIs
$0.0463
-0(-0%)
as of June 3, 2026
Try our APIs with
free plan!
Humacyte Inc Financial Data Overview
Price chart is built with
Anychart
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.
Prev. Close
0.0463
Open
0.046
High
0.0465
Low
0.046
52 wk Range
0.04-0.6
Market Cap
0
Revenue
2 016 K
EPS
-0.7181
Beta
2.308
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Humacyte Inc data using free add-ons & libraries
Get Humacyte Inc Fundamental Data
Humacyte Inc Fundamental data includes:
- Net Revenue: 2 016 K
- EBITDA: -105 185 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-09-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Humacyte Inc News
New
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors
Humacyte, Inc. (HUMA) closed at $0.61 in the latest trading session, marking a -6.63% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.08%. Meanwhile, the Dow ex...
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
Humacyte, Inc. (HUMA) closed at $0.59 in the latest trading session, marking a -2.44% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. At the same time, ...
Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity
Humacyte, Inc. (NASDAQ:HUMA) is one of the penny stocks with potential to rise 1000 percent. On March 27, 2026, BTIG maintained its Buy rating on Humacyte but cut its price target to $3 from $6 after...
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates
Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.16 per share a year ago. These figures are adjusted for...
Get Humacyte Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
